Dividend Growth Stocks: New Golden Investment: AbbVie Inc. (ABBV)


Wouldn’t it be nice to buy investments that you could not lose money on and that only had upside. While we are wishing why don’t we add in predictable earnings, predictable dividends and, of coarse, we don’t want to pay a premium for this investment. Does this sound unrealistic? Maybe, but we can have the next best thing – a Golden Investment. So what exactly is a Golden Investment?

Golden Investments

The concept did not originate with me, and others have different names for it, including ‘zero-basis stock.’ I don’t care for that name since, in reality it is nearly impossible to hold a stock with zero basis (at least the way the IRS calculates basis). A Golden Investment is one in which I have fully recovered my entire investment either through dividends or from partial liquidation or a combination of both.

Golden Investments Portfolio

I am pleased to announce that Clough Global Equity Fund (GLQ) has now earned Golden Investment status. With its August 31, 2022 dividend, proceeds from the dividends received, now account for 100.7% of my original investment. 

In my income portfolio, I am currently holding these Golden Investments with several more going Golden in the next 24 months:

Main Street Capital (MAIN) | YOC: 10.3% | Current Yield: 6.2%
This stock was originally purchased in July 2012. I never bought any more, but just collected the dividends. It went Golden in February 2022.

AbbVie Inc. (ABBV) | YOC: 18.2% | Current Yield: 4.1%
This stock was originally purchased in January 2013. With two additional purchases in 2013. I have been collecting dividends every since. It went Golden in August 2022.


Image and article originally from www.dividend-growth-stocks.com. Read the original article here.

By Unknown